Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC)

Cancer Letters

Volumn 249, Issue 2, 2007, Pages 171-177

  Krzystek Korpacka, Malgorzata ^a   Matusiewicz, Malgorzata ^a   Diakowska, Dorota ^a   Grabowski, Krzysztof ^a   Blachut, Katarzyna ^a   Banas, Teresa ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Lymph node involvement; Metastasis; Squamous cell carcinoma of esophagus; Tumor marker; VEGF A; VEGF C

Indexed keywords

TUMOR MARKER; VASCULOTROPIN A; VASCULOTROPIN C;

ACCURACY; ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; LEUKOCYTE COUNT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 33947402251     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.08.011     Document Type: Article

References (37)

1. Enzinger P.C., and Mayer R.J. Esophageal cancer. N. Engl. J. Med. 349 (2003) 2241-2252
2. Wilting J., Hawighorst T., Hecht M., Christ B., and Papoutsi M. Development of lymphatic vessels: tumour lymphangiogenesis and lymphatic invasion. Curr. Med. Chem. 12 (2005) 3043-3053
3. Lerut T., Coosemans W., Decker G., De Leyn P., Moons J., Nafteux P., and Van Raemdonk D. Surgical techniques. J. Surg. Oncol. 92 (2005) 218-229
4. Tammela T., Enholm B., Alitalo K., and Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc. Res. 65 (2005) 550-563
5. Bjorndahl M.A., Cao R., Burton J.B., Brakenhielm E., Religa P., Galter D., Wu L., and Cao Y. Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 65 (2005) 9261-9268
6. Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L.F., and Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201 (2005) 1089-1099
7. He Y., Karpanen T., and Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim. Biophys. Acta 1654 (2004) 3-12
8. Kitadai Y., Haruma K., Tokutomi T., Tanaka S., Sumii K., Carvalho M., Kuwabara M., Yoshida K., Hirai T., Kajiyama G., and Tahara E. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin. Cancer Res. 4 (1998) 2195-2200
9. Shintani S., Li Ch., Ishikawa T., Mihara M., Nakashiro K., and Hamakawa H. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol. 40 (2004) 13-20
10. Tamura M., Oda M., Tsunezuka Y., Matsumoto I., Kawakami K., Ohta Y., and Watanabe G. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 126 (2004) 342-346
11. Kitadai Y., Amioka T., Haruma K., Tanaka S., Yoshihara M., Sumii K., Matsutani N., Yasui W., and Chayama K. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int. J. Cancer 93 (2001) 662-666
12. Kleespies A., Bruns C.J., and Jauch K.W. Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies. Onkologie 28 (2005) 281-288
13. Sobin L.H., and Wittekind C. TNM classification of malignant tumors. sixth ed. (2002), John Wiley and Sons, Hoeboken, New Jersey
14. Mealy K., Feely J., Reid I., McSweeney J., Walsh T., and Hennessy T.P.J. Tumour marker detection in oesophageal carcinoma. Eur. J. Surg. Oncol. 22 (1996) 505-507
15. Shimada H., Nabeya Y., Tagawa M., Okazami S., Matsubara H., Kadomatsu K., Muramatsu T., Ikematsu S., Sakuma S., and Ochiai T. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma. Cancer Sci. 94 (2003) 628-632
16. Shimada H., Nabeya Y., Okazami S., Matsubara H., Shiratori T., Gunji Y., Kobayashi S., Hayashi H., and Ochiai T. Prediction of survival with squamous cel carcinoma antigen in patients with respectable esophageal squamous cell carcinoma. Surgery 133 (2003) 486-494
17. Kosugi S., Nishimaki T., Kanda T., Nakagawa S., Ohashi M., and Hatakeyama K. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J. Surg. 28 (2004) 680-685
18. Shimada Y., Watanabe G., Kawamura J., Soma T., Okabe M., Ito T., Inoue H., Kondo M., Mori Y., Tanaka E., and Imamura M. Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers. Oncology 68 (2005) 285-292
19. Tew W.P., Kelsen D.P., and Ilson D.H. Targeted therapies for esophageal cancer. Oncologist 10 (2005) 590-601
20. Byeon J.S., Jung H.Y., Lee Y.J., Lee D., Lee G.H., Myung S.J., Yang S.K., Hong W.S., Kim J.H., Min Y.I., and Kim J.S. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma. J. Gastroenterol. Hepatol. 19 (2004) 648-654
21. Kimura Y., Watanabe M., Ohga T., Saeki H., Kakaeji Y., Baba H., and Maehara Y. Vascular endothelial growth factor-C expression correlates with lymphatic involvement and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol. Rep. 10 (2003) 1747-1753
22. Noguchi T., Takeno S., Shibata T., Uchida Y., Yokoyama S., and Muller W. VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. Oncol. Rep. 9 (2002) 995-999
23. Su J.L., Yang P.C., Shih J.Y., Yang C.Y., Wei L.H., Hsieh C.Y., Chou C.H., Jeng Y.M., Wang M.Y., Chang K.J., Hung M.C., and Kuo M.L. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9 (2006) 209-223
24. Duff S.E., Saunders M., McCredie V., Kumar S., O'Dwyer S.T., and Jayson G.C. Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer. Clin. Oncol. 17 (2005) 367-371
25. Mitsuhashi A., Suzuka K., Yamazawa K., Matsui H., Seki K., and Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer 103 (2005) 724-730
26. Niki T., Iba S., Tokunou M., Yamada T., Matsuno Y., and Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin. Cancer Res. 6 (2000) 2431-2439
27. Kinoshita J., Kitamura K., Kabashima A., Saeki H., Tanaka S., and Sugimachi K. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer. Res. Treat. 66 (2001) 159-164
28. Duff S.E., Jeziorska M., Rosa D.D., Kumar S., Haboubi N., Sherlock D., O'Dwyer S.T., and Jayson G.C. Vascular endothelial growth factors and receptors in colorectal cancer: implications for anti-angiogenic therapy. Eur. J. Cancer 42 (2006) 112-117
29. McCarter M.D., Clarke J.H., and Harken A.H. Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis. Surgery 135 (2004) 121-124
30. Sato F., Shimada Y., Watanabe G., Uchida S., Makino T., and Imamura M. Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer. Br. J. Cancer 80 (1999) 1366-1372
31. Shimada H., Takeda A., Nabeya Y., Okazumi S.I., Matsubara H., Funami Y., Hayashi H., Gunji Y., Kobayashi S., Suzuki T., and Ochiai T. Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma. Cancer 92 (2001) 663-669
32. Kyzas P.A., Cunha I.W., and Ioannidis J.P. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. Clin. Cancer Res. 11 (2005) 1434-1440
33. Kishimoto K., Sasaki A., Yoshihama Y., Mese H., Tsukamoto G., and Matsumura T. Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncol. 39 (2003) 391-396
34. Sato T., Iizuka N., Hamamoto Y., Yoshino S., Abe T., Takeda S., Uchimura S., Miyamoto T., Sei F., Hamada K., Yamada-Okabe H., and Oka M. Esophageal squamous cell carcinomas with distinct invasive depth show different gene expression profiles associated with lymph node metastasis. Int. J. Oncol. 28 (2006) 1043-1055
35. Wartiovaara U., Salven P., Mikkola H., Lassila R., Kaukonen J., Joukov V., Orpana A., Ristimaki A., Heikinheimo M., Joensuu H., Alitalo K., and Palotie A. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemost. 80 (1998) 171-175
36. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J. Clin. Invest. 115 (2005) 2316-2319
37. Mathur S.P., Mathur R.S., Gray E.A., Lane D., Underwood P.G., Kohler M., and Creasman W.T. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A. Gynecol. Oncol. 98 (2005) 467-483